• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BNO
Click for more information
5.26% 20.0¢

BIONOMICS LIMITED - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
BNO Executive Chairman Extension of Appointment15/03/19
BNO S&P DJI Announces March 2019 Quarterly RebalancePRICE SENSITIVE08/03/19
BNO Further Analysis of Phase 2 PTSD Trial Results PresentationPRICE SENSITIVE18/02/19
BNO Further Analysis of Phase 2 PTSD ResultsPRICE SENSITIVE18/02/19
BNO Half Yearly Report and AccountsPRICE SENSITIVE15/02/19
BNO Appendix 4C - quarterlyPRICE SENSITIVE31/01/19
BNO BNO at Neuroscience Innovation Forum and Biotech Showcase04/01/19
BNO BNC105 Clinical Trial In Combination With NivolumabPRICE SENSITIVE04/01/19
BNO Bionomics Receives $650k Licensing Revenue from CTxPRICE SENSITIVE21/12/18
BNO Appendix 3B13/12/18
BNO Bionomics Receives Over $6.5m R&D Tax Incentive RefundPRICE SENSITIVE11/12/18
BNO SPP Completed10/12/18
BNO Initial Director's Interest Notice23/11/18
BNO Bionomics Share Purchase Plan Offer22/11/18
BNO Change in substantial holding20/11/18
BNO Cleansing Notice16/11/18
BNO Appendix 3B16/11/18
BNO Final Director's Interest Notice15/11/18
BNO Executive Chairman Appointment - Material Contract Terms15/11/18
BNO ASX Notification of Results 201814/11/18
BNO CEO 2018 AGM PresentationPRICE SENSITIVE14/11/18
BNO Executive Chairman 2018 AGM PresentationPRICE SENSITIVE14/11/18
BNO FUND RAISING UPDATEPRICE SENSITIVE14/11/18
BNO Capital Raise Update and Conference/Webcast Call13/11/18
BNO Capital Raise Update and Conference Call12/11/18
BNO Trading HaltPRICE SENSITIVE12/11/18
BNO Recapitalisation by major US-based biotechnology investorPRICE SENSITIVE09/11/18
BNO Leadership Changes and Strategic ReviewPRICE SENSITIVE09/11/18
BNO Appendix 4C - quarterlyPRICE SENSITIVE29/10/18
BNO Appendix 4G / Corporate Governance Statement12/10/18
BNO Bionomics Annual Report 201812/10/18
BNO Notice of Annual General Meeting/Proxy Form12/10/18
BNO Change in substantial holding05/10/18
BNO Bionomics' PTSD Trail Results PresentationPRICE SENSITIVE02/10/18
BNO Bionomics' PTSD Trial ResultsPRICE SENSITIVE02/10/18
BNO Trading HaltPRICE SENSITIVE28/09/18
BNO BNO to Host KOL Call on BNC210 and Treatment of Agitation04/09/18
BNO Date of 2018 Annual General Meeting31/08/18
BNO Appendix 3B24/08/18
BNO Securities Trading Policy17/08/18
BNO Full Year Statutory Accounts16/08/18
BNO Bionomics 2017/2018 Preliminary Final ResultsPRICE SENSITIVE16/08/18
BNO Bionomics Presents at Annual Bioshares Biotech Summit27/07/18 download Created with Sketch. 1.23MB
BNO Appendix 4C - quarterlyPRICE SENSITIVE20/07/18 download Created with Sketch. 258.5KB
BNO End-of-Treatment Milestone Met in Phase 2 PTSD TrialPRICE SENSITIVE09/07/18 download Created with Sketch. 110.08KB
BNO Appendix 3B02/07/18 download Created with Sketch. 209.1KB
BNO Bionomics NOW Newsletter June 201825/06/18 download Created with Sketch. 622.68KB
BNO Ceasing to be a substantial holder15/06/18 download Created with Sketch. 104.62KB
BNO Appendix 3B08/06/18 download Created with Sketch. 209.13KB
BNO Commencement of BNC210 Phase 2 Agitation TrialPRICE SENSITIVE23/05/18 download Created with Sketch. 115.67KB
BNO Appendix 3B07/05/18
BNO Appendix 4C - quarterlyPRICE SENSITIVE30/04/18
BNO Appendix 3B20/04/18
BNO Bionomics Presents BNC101 and BNC105 Data at AACR ConferencePRICE SENSITIVE13/04/18
BNO Phase 2 PTSD Clinical Trial Fully Recruited11/04/18
BNO Appendix 3B09/04/18
BNO Bionomics to Host KOL Meetings in New York and London06/04/18
BNO Appendix 3B29/03/18
BNO Appendix 3B16/03/18
BNO Change in substantial holding05/03/18
BNO Half Yearly Report and AccountsPRICE SENSITIVE14/02/18
BNO Bionomics NOW Newsletter February 201805/02/18
BNO Appendix 4C - quarterlyPRICE SENSITIVE31/01/18
BNO Bionomics Receives Over $6.7m R&D Tax Incentive RefundPRICE SENSITIVE16/01/18
BNO BNO to Feature at NIF and Biotech Showcase in San Francisco05/01/18
BNO Change of Director's Interest Notice18/12/17
BNO Appendix 3B18/12/17
BNO Change of Director's Interest Notice08/12/17
BNO Appendix 3B08/12/17
BNO Change of Director's Interest Notice24/11/17
BNO Appendix 3B24/11/17
BNO Results of Meeting15/11/17
BNO CEO & Managering Director's Report to Shareholders15/11/17
BNO Chairman's Address to Shareholders15/11/17
BNO Appendix 4C - quarterlyPRICE SENSITIVE31/10/17
BNO BNC101 Phase 1 Clinical Trial Recruitment CompletedPRICE SENSITIVE31/10/17
BNO Appendix 3B30/10/17
BNO Bionomics & MSD to Host 5th Annual Neuroscience Symposium26/10/17
BNO Appendix 4G / Corporate Governance Statement13/10/17
BNO Notice of Annual General Meeting/Proxy Form13/10/17
BNO Bionomics Annual Report 201713/10/17
BNO ASX Spotlight New York Presentation12/10/17
BNO Change of Director's Interest Notice04/10/17
BNO Appendix 3B04/10/17
BNO Date of 2017 Annual General Meeting12/09/17
BNO Appendix 3B06/09/17
BNO Bionomics to Present at Rodman & Renshaw Conference04/09/17
BNO Bionomics BNC210 to Feature at the 30th ECNP Congress01/09/17
BNO Appendix 3B21/08/17
BNO Bionomics & MSD 5th Annual Neuroscience Symposium21/08/17
BNO Change of Director's Interest Notice18/08/17
BNO Full Year Statutory Accounts16/08/17
BNO Bionomics 2016/2017 Preliminary Final ResultsPRICE SENSITIVE16/08/17
BNO Appendix 4C - quarterlyPRICE SENSITIVE27/07/17
BNO Bionomics Added to OTCQX Composite and International Indices24/07/17
BNO Bionomics Presents at 13th Annual Bioshares Biotech Summit21/07/17
BNO Appendix 3B18/07/17
BNO Appendix 3B28/06/17
BNO Change in substantial holding20/06/17
BNO Bionomics Presents on BNC210 at PTSD State of Science Summit15/06/17
BNO Executive Chairman Extension of Appointment
15/03/19
BNO S&P DJI Announces March 2019 Quarterly Rebalance
08/03/19PRICE SENSITIVE
BNO Further Analysis of Phase 2 PTSD Trial Results Presentation
18/02/19PRICE SENSITIVE
BNO Further Analysis of Phase 2 PTSD Results
18/02/19PRICE SENSITIVE
BNO Half Yearly Report and Accounts
15/02/19PRICE SENSITIVE
BNO Appendix 4C - quarterly
31/01/19PRICE SENSITIVE
BNO BNO at Neuroscience Innovation Forum and Biotech Showcase
04/01/19
BNO BNC105 Clinical Trial In Combination With Nivolumab
04/01/19PRICE SENSITIVE
BNO Bionomics Receives $650k Licensing Revenue from CTx
21/12/18PRICE SENSITIVE
BNO Appendix 3B
13/12/18
BNO Bionomics Receives Over $6.5m R&D Tax Incentive Refund
11/12/18PRICE SENSITIVE
BNO SPP Completed
10/12/18
BNO Initial Director's Interest Notice
23/11/18
BNO Bionomics Share Purchase Plan Offer
22/11/18
BNO Change in substantial holding
20/11/18
BNO Cleansing Notice
16/11/18
BNO Appendix 3B
16/11/18
BNO Final Director's Interest Notice
15/11/18
BNO Executive Chairman Appointment - Material Contract Terms
15/11/18
BNO ASX Notification of Results 2018
14/11/18
BNO CEO 2018 AGM Presentation
14/11/18PRICE SENSITIVE
BNO Executive Chairman 2018 AGM Presentation
14/11/18PRICE SENSITIVE
BNO FUND RAISING UPDATE
14/11/18PRICE SENSITIVE
BNO Capital Raise Update and Conference/Webcast Call
13/11/18
BNO Capital Raise Update and Conference Call
12/11/18
BNO Trading Halt
12/11/18PRICE SENSITIVE
BNO Recapitalisation by major US-based biotechnology investor
09/11/18PRICE SENSITIVE
BNO Leadership Changes and Strategic Review
09/11/18PRICE SENSITIVE
BNO Appendix 4C - quarterly
29/10/18PRICE SENSITIVE
BNO Appendix 4G / Corporate Governance Statement
12/10/18
BNO Bionomics Annual Report 2018
12/10/18
BNO Notice of Annual General Meeting/Proxy Form
12/10/18
BNO Change in substantial holding
05/10/18
BNO Bionomics' PTSD Trail Results Presentation
02/10/18PRICE SENSITIVE
BNO Bionomics' PTSD Trial Results
02/10/18PRICE SENSITIVE
BNO Trading Halt
28/09/18PRICE SENSITIVE
BNO BNO to Host KOL Call on BNC210 and Treatment of Agitation
04/09/18
BNO Date of 2018 Annual General Meeting
31/08/18
BNO Appendix 3B
24/08/18
BNO Securities Trading Policy
17/08/18
BNO Full Year Statutory Accounts
16/08/18
BNO Bionomics 2017/2018 Preliminary Final Results
16/08/18PRICE SENSITIVE
BNO Bionomics Presents at Annual Bioshares Biotech Summit
27/07/18 download Created with Sketch. 1.23MB
BNO Appendix 4C - quarterly
20/07/18PRICE SENSITIVE download Created with Sketch. 258.5KB
BNO End-of-Treatment Milestone Met in Phase 2 PTSD Trial
09/07/18PRICE SENSITIVE download Created with Sketch. 110.08KB
BNO Appendix 3B
02/07/18 download Created with Sketch. 209.1KB
BNO Bionomics NOW Newsletter June 2018
25/06/18 download Created with Sketch. 622.68KB
BNO Ceasing to be a substantial holder
15/06/18 download Created with Sketch. 104.62KB
BNO Appendix 3B
08/06/18 download Created with Sketch. 209.13KB
BNO Commencement of BNC210 Phase 2 Agitation Trial
23/05/18PRICE SENSITIVE download Created with Sketch. 115.67KB
BNO Appendix 3B
07/05/18
BNO Appendix 4C - quarterly
30/04/18PRICE SENSITIVE
BNO Appendix 3B
20/04/18
BNO Bionomics Presents BNC101 and BNC105 Data at AACR Conference
13/04/18PRICE SENSITIVE
BNO Phase 2 PTSD Clinical Trial Fully Recruited
11/04/18
BNO Appendix 3B
09/04/18
BNO Bionomics to Host KOL Meetings in New York and London
06/04/18
BNO Appendix 3B
29/03/18
BNO Appendix 3B
16/03/18
BNO Change in substantial holding
05/03/18
BNO Half Yearly Report and Accounts
14/02/18PRICE SENSITIVE
BNO Bionomics NOW Newsletter February 2018
05/02/18
BNO Appendix 4C - quarterly
31/01/18PRICE SENSITIVE
BNO Bionomics Receives Over $6.7m R&D Tax Incentive Refund
16/01/18PRICE SENSITIVE
BNO BNO to Feature at NIF and Biotech Showcase in San Francisco
05/01/18
BNO Change of Director's Interest Notice
18/12/17
BNO Appendix 3B
18/12/17
BNO Change of Director's Interest Notice
08/12/17
BNO Appendix 3B
08/12/17
BNO Change of Director's Interest Notice
24/11/17
BNO Appendix 3B
24/11/17
BNO Results of Meeting
15/11/17
BNO CEO & Managering Director's Report to Shareholders
15/11/17
BNO Chairman's Address to Shareholders
15/11/17
BNO Appendix 4C - quarterly
31/10/17PRICE SENSITIVE
BNO BNC101 Phase 1 Clinical Trial Recruitment Completed
31/10/17PRICE SENSITIVE
BNO Appendix 3B
30/10/17
BNO Bionomics & MSD to Host 5th Annual Neuroscience Symposium
26/10/17
BNO Appendix 4G / Corporate Governance Statement
13/10/17
BNO Notice of Annual General Meeting/Proxy Form
13/10/17
BNO Bionomics Annual Report 2017
13/10/17
BNO ASX Spotlight New York Presentation
12/10/17
BNO Change of Director's Interest Notice
04/10/17
BNO Appendix 3B
04/10/17
BNO Date of 2017 Annual General Meeting
12/09/17
BNO Appendix 3B
06/09/17
BNO Bionomics to Present at Rodman & Renshaw Conference
04/09/17
BNO Bionomics BNC210 to Feature at the 30th ECNP Congress
01/09/17
BNO Appendix 3B
21/08/17
BNO Bionomics & MSD 5th Annual Neuroscience Symposium
21/08/17
BNO Change of Director's Interest Notice
18/08/17
BNO Full Year Statutory Accounts
16/08/17
BNO Bionomics 2016/2017 Preliminary Final Results
16/08/17PRICE SENSITIVE
BNO Appendix 4C - quarterly
27/07/17PRICE SENSITIVE
BNO Bionomics Added to OTCQX Composite and International Indices
24/07/17
BNO Bionomics Presents at 13th Annual Bioshares Biotech Summit
21/07/17
BNO Appendix 3B
18/07/17
BNO Appendix 3B
28/06/17
BNO Change in substantial holding
20/06/17
BNO Bionomics Presents on BNC210 at PTSD State of Science Summit
15/06/17
refresh Created with Sketch. REFRESH
 

Top Stories

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
Week 47 Wrap: HotCopper users' most watched; Brent lifts on Putin's scary letter; RFK dents CSL Welcome to the end of another week. Let's start with what HotCopper users have been watching and discussing.
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.